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Background: Stroke is the 3rd largest cause of death in the US. Carotid artery stenting (CAS) is an advanced technology for stroke prevention. 
The NCDR- CARE national database tracks outcomes of both CAS and conventionally treated carotid endarterectomy patients. Two major methods of 
neurologic follow up are employed in the categorization of these patients: National Institute of Health Stroke Scale (NIHSS) and reported diagnosis 
(RD). How well these two outcome measures correlate with each other is unknown.
Methods: We analyzed 6023 CAS patients from 168 centers enrolled in the CARE Registry from Jan 2005 to Dec 2010. New strokes post 
procedure was defined as a NIHSS change of ≥ 2 from baseline or the RD of a new stroke. Both outcome measures were compared for each patient. 
Categorical variables were analyzed with r2 while quantitative variables with the Student’s t-test. Cohen’s kappa coefficient was calculated to assess 
agreement between RD and NIHSS.
Results: Post-procedural new strokes were reported in 276 (5%) of 6023 patients by NIHSS or RD. Only 1.4% (n=87) patients were reported by 
both NIHSS and RD to have had a new stroke. However, a discordant outcome reported by NIHSS and RD was found in 3.1% (n=189) patients. Using 
NIHSS 64 patients had a new stroke with no RD stroke, while 125 patients had an RD new stroke with no NIHSS stroke (kappa coefficient = 0.46, 
only moderate agreement). There were no significant differences between the concordant reports of new strokes versus discordant reports of new 
strokes when it came to hospital region, teaching facility, number of beds, inclusion in clinical trials, hospital type, location. There were however, a 
significantly larger proportion of patients with RD only strokes with prior strokes (16% v 12.9%), transient ischemic attacks (TIA) (36% v 28.7%), 
symptomatic target lesions (43.3% v 34.5%) when compared to the RD and NIHSS negative patients (all p<0.001).
Conclusion: We would recommend that due to the standardized nature of the NIHSS, the ability to easily certify examiners on-line, it is the more 
reliable measure of new strokes, particularly since RD may be subject to misclassification of patients with prior stokes or TIAs.
